Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novartis in-licenses CYT002-NicQb for treatment of nicotine addiction

April 26, 2007

Vivitrol filed for approval in U.K. and Germany

April 5, 2007

Nicotine patch appears safe for use in coronary artery disease patients

April 4, 2007

Exjade filed in Japan

April 3, 2007

Positive preclinical profile of the CRF1 antagonist MTIP in animal models of alcoholism

March 27, 2007

EVT-302 for smoking cessation begins clinical testing

March 26, 2007

Cleveland BioLabs to submit Protectan CBLB-502 in response to RFP

March 23, 2007

GTC grants expanded license to PharmAthene in support of Protexia

March 15, 2007

Enrollment complete in phase I/II study of ALKS-29 in alcohol dependence

March 8, 2007

Extended-release QuitPak begins pilot study for smoking cessation

Feb. 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.